Globe Life (GL) beat expectations in FY2026 on revenue of $25.3B versus the $24.7B estimate (+22.6% YoY) and EPS of $1.90. Below is the full Globe Life earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
Globe Life (GL) Earnings Analysis — key stats
Next earnings date
Feb 6, 2025
Latest reported quarter
FY2026
Earnings verdict
Beat
Revenue
$25.3B (vs $24.7B est · +2.6% surprise · +22.6% YoY)
EPS
$1.90 (vs $1.80 est · +5.6% surprise · +0.3% YoY)
Share price
$555.54 (+1.8%)
Market cap
$880.0B
What you'll find
Next Globe Life (GL) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Globe Life reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Globe Life (GL)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Globe Life's next earnings date?
Globe Life's (GL) next scheduled earnings date is Feb 6, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Globe Life (GL) beat or miss earnings?
In FY2026, Globe Life (GL) posted beat results — revenue of $25.3B versus the $24.7B estimate (+2.6% surprise) and EPS of $1.90 versus $1.80 expected (+5.6% surprise). Magnisto decodes every Globe Life (GL) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Globe Life (GL) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Globe Life (GL), anchored to the current $555.54 share price, so you can weigh the bull, base and bear cases for Globe Life side by side.
Is Globe Life (GL) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Globe Life fits your own thesis and risk profile. This is research, not investment advice.